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Abstract
Travelers’ Diarrhea is the number one cause of childhood death in the world.
Enteroaggregative Escherichia coli (EAEC) is one of the main causes of this disease. EAEC
adhere to the surface of the intestine and stack in a brick-like pattern. Via an unstudied quorumsensing mechanism, these bacteria express a variety of virulence factors that lead to diarrhea.
The long-term goal of this research is to elucidate the mechanism by which EAEC changes from
benign to virulent. A previously-unstudied open-reading frame in EAEC, AggR activated
repressor (Aar), has recently been hypothesized to act as one of the major transcription factors
influencing virulence. Here, we describe two viable methods for purification and a method for
cleavage. Circular dichroism (CD) data suggests a partially α-helical structure. Further tests,
including multi-dimensional NMR and X-ray crystallography, are currently being conducted to
determine the tertiary structure of the protein.
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Introduction
Diarrhea is a condition that produces three or more loose or liquid stools in a 24 hour
period. Although diarrhea affects adults and children, the severity of the disease in children is far
greater. According to the World Health Organization (WHO), diarrhea is the leading causes of
mortality and morbidity in the world, killing roughly 760,000 children per year under the age of
five (World Health Organization, 2014). Most children experience diarrhea due to pathogenic
bacterial species like Escherichia coli (E. coli).
Diarrhea can be induced by bacterial infections. According to the Centers for Disease
control, six different pathogenic strains of E. coli exist, Shiga toxin-producing (STEC),
Enterotoxigeneic (ETEC), Enteropathogenic (EPEC), Enteroinvasive (EIEC), Diffusely adherent
(DAEC) and Enteroaggregative (EAEC) (Centers for Disease Control [CDC], 2014). All
pathotypes utilize adhesion proteins to line the mucosal walls of the intestines (Kaper, Nataro, &
Harry, 2004). EIEC utilizes mechanical mechanisms to induce symptoms (Van Den Beld &
Reubsaet, 2012). STEC, ETEC, EPEC, DIEC and EAEC contain additional genes that produce
enterotoxins, increasing Cl- permeability (Stark & Duncan, 1972). This results in Ca2+ and H2O
leakage into the lumen (Stark & Duncan, 1972). Although these five pathotypes have similar
severities, the prevalence of EAEC is far greater than that of STEC, ETEC, EPEC and DIEC in
children.
The prevalence of EAEC in young populations is highlighted by a study conducted in
Mongolia between 2001 and 2002. Sarantuya et al. collected 238 E. coli isolates from children,
aged zero to 16, with sporadic diarrhea (> three watery stools a day) and 278 E. coli isolates from
apparently healthy children (Sarantuya et al., 2004). The results of cultured stool samples
indicated four different pathotypes of diarrheagenic E. coli: ETEC, EPEC, EIEC and EAEC.
6

However, the incidence of EAEC (15.1%) was far higher than the incidence of any other
pathotype (0 to 6%) in the entire cohort (Sarantuya et al., 2004). More importantly, the group
examined the incidence of EAEC between the diarrheal population and the control population.
The percentage of EAEC was greater in the diarrheal group (36%) than the control group
(16%)(p < 0.0006) (Table 1), suggesting that EAEC can be a pathogenic species of bacteria
(Sarantuya et al., 2004). Sarantuya et al. also collected data about AggR, a virulence factor
commonly found in the genome of pathogenic EAEC. As indicated in Table 1, AggR is more
common in the diarrheal group (19%) than in the non-diarrheal group (4%) (p < 0.0004)
(Sarantuya et al., 2004). These data suggest that AggR likely contributes to pathogenicity of
EAEC (Sarantuya et al., 2004).
Table 1. Prevalence of diarrheagenic E. coli categories of among E. coli strains examined in
Mongolian cohort (Sarantuya et al., 2004).

Several studies have highlighted a strong relationship between the presence of AggR and
diarrheal disease (Boisen et al., 2014; Sarantuya et al., 2004). This relationship has led to
multiple AggR characterization studies. Unpublished data by Nataro et al. suggested that there
was a positive correlation between AggR and aggregative adherence fimbria (AAF/I). The
relationship was probed to determine if AggR controlled AAF/I expression. AggR-knockout and
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wildtype cells were subjected to immunogold electron microscopy (Nataro, Yikang, Yingkang,
& Walker, 1994). AggR-knockouts lacked observable fimbria in the images, while the wildtype
cell contained visible fimbria (Nataro et al., 1994). Additional studies confirmed that AggR
controls transcription of AAF/I (Nataro et al., 1994). Protein homology studies also suggest that
AggR is a member of the AraC/XylS family of transcriptional regulators, alluding to its
transcriptional control potential (Nataro et al., 1994). Regulon characterization also determined
at least 44 other genes under AggR transcriptional control (Morin, Santiago, Ernst, Guillot, &
Nataro, 2013). Sixteen of these genes are part of the Aai T6SS system, responsible for protein
transport across membranes (Morin et al., 2013). Five genes are part of the dispersin secretion
system, responsible for a surface coat that acts to disperse bacteria, and four genes are part of the
AAF/II fimbrial biogenesis system, responsible for fimbria production (Morin et al., 2013). In a
separate study, Morin et al. concluded that AggR autoactivates, creating a positive feedback loop
(Morin et al., 2010). Although autoactivation ensures rapid stimulation and virulence factor
production upon entry into conducive environments, positive feedback is potentially maladaptive
to optimal bacterial growth by expelling the bacteria before the optimal bacterial load is reached
(Santiago et al., 2014) Therefore, AggR likely also uses a negative feedback regulator.

Morin et al. found an additional hypothetical protein in the AggR regulon that lacked
homology to any characterized proteins (Morin et al., 2013). Santiago et al. conducted multiple
sequence alignments to determine if this hypothetical protein was present in other species
(Santiago et al., 2014). As seen in Figure 1, the hypothetical protein is found in E. coli
pathotypes (EHEC, EPEC, STEC, ETEC, EIEC, EAEC) and other pathogenic bacterial
species(Santiago et al., 2014). This hypothetical protein is termed AggR-activated regulator
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Figure 1. Phylogenic analysis using ClustalW in various pathogenic species. EAEC species are
highlighted in orange. Adapted figure (Santiago et al., 2014).
9

(Aar), and is hypothesized to be the AggR negative regulator(Santiago et al., 2014). Recent work
shows that Aar RNA levels are upregulated by AggR (Santiago et al., 2014). Santiago et al.
studied the relationship between AggR upregulation and Aar upregulation. The data indicate that
AggR expression and Aar expression are inversely related (Santiago et al., 2014). From these
data, three mechanisms of control are likely: i) Aar binds DNA, thus occluding a specific DNA
sequence from AggR ii) Aar binds directly to AggR, thereby either changing the conformation
of AggR, or blocking the AggR DNA binding site iii) Aar indirectly influences AggR through
an unknown intermediate. Unpublished surface plasmon resonance (SPR) data suggests that
there is a direct interaction between AggR and Aar. However, no structural data exists to validate
the mechanism of inhibition.
Aar is attracting increased attention from the global health community due to its
virulence regulation potential. This work provides a valid purification strategy for Aar from other
contaminates and fusion partners. Furthermore, there is preliminary secondary structure
information of Ubiquitin-Aar. Additional investigations are being conducted to elucidate the
three-dimensional, high resolution structure. Structural data could theoretically lead to a
regulatory loop, decreasing prevalence and pathogenicity of EAEC and other pathogens in
children.
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Materials and Methods
Transformation and Cell Lysis – Ubiquitin-Aar/Aar-Ubiquitin
BL21 (DE3) supercompetant cells were used for all transformations in these experiments.
Cultures in Luria brother (LB) were induced at 37 degrees Celsius with IPTG at an OD600 = 0.60.8. Once induced for 4 hours, cells were centrifuged at 4,000 rpm for 10 minutes and frozen at
-80 degrees Celsius for 16 hours. The pellet was resuspended in histidine binding buffer (HBB)
(10mM NaH2PO4, pH 8.0, 0.3M NaCl, 10mM Imidazole, 1mM PMSF). Sonication was
performed on ice with the FB120 Sonicator (Fisher Scientific) (100 percent intensity, 10 second
intervals, 30 seconds/mL). The lysate was then centrifuged for 30 minutes at 14,000 rpm.
Purification— Ubiquitin-Aar
The protein was purified using standard Ni2+ procedures (Rudloff, Woosley, & Wright,
2015). The cell lysate was passed over Ni2+ column, equilibrated in HBB and washed with 5
column volumes of histidine wash buffer (HWB) (10mM NaH2PO4, pH 8.0, 0.3M NaCl, 60mM
Imidazole, 1mM PMSF). The protein was eluted in histidine elution buffer (HEB) (10mM
NaH2PO4, pH 8.0, 0.3M NaCl, .25M Imidazole). The flow through (FT) was then collected,
diluted (1:10) and loaded onto a sulfopropyl (S) column. FT was discarded and the column was
washed with three column volumes (10mM NaH2PO4, pH 8.0, 25mM NaCl). The protein was
eluted in 15 mL of elution buffer (10mM NaH2PO4, pH 8.0, 200mM NaCl and 10mM NaH2PO4,
pH 8.0, 500mM NaCl, respectively), collected and concentrated at 4,000 rpm for 90 minutes in a
swinging bucket centrifuge using a Spin-X UF concentrator (Corning) (10k MWCO PES).
Circular Dichroism – Ubiquitin-Aar
Circular dichroism was performed on J-810 sprectropolarimeter (Jasco). All CD
experiments were conducted in a 1 mm pathlength cuvette at 5µM protein (50mM NaPO4, 250
11

mM NaCl). Spectra were collected at pH 7.0 and pH 7.5. Ubiquitin samples were obtained from
the Berndsen laboratory at James Madison University.
Transformation and Cell Lysis – Aar-MBP
Cells were obtained from the Nataro laboratory at the University of Virginia. The bacteria
containing the MBP-Aar construct was grown and lysed according to the pMALTM Protein
Fusion and Purification Manual. Transformed cells were grown in rich Luria broth + glucose
(2g/L) to an OD600 = 0.6-0.8 and induced with IPTG. Once induced, cells were incubated for 4
hours, centrifuged at 4,000 rpm for 10 minutes and then frozen at

-20 degrees Celsius

overnight. The pellet was resuspended in column buffer (CB)(20mM Tris-HCl, pH 7.5, 200mM
NaCl, 1 mM EDTA, 1mM PMSF) and sonicated using the FB120 Sonicator (Fisher Scientific)
(75% intensity ,10 second intervals, 1 minute/mL).
Purification – Aar-MBP
Purification was done using the pMALTM Protein Fusion and Purification Manual (New
England BioLabs, Inc., 2015). The crude extract was diluted 1:6 using CB and loaded onto an
amylose column (New England BioLabs, Inc.). The column was washed with 5 column volumes
of CB and eluted with 15 mL of MBP elution buffer (20mM Tris-HCl, pH 7.5, 200mM NaCl, 1
mM EDTA, 10mM maltose). The sample was concentrated at 4,000 rpm for 90 minutes using
the Spin-X UF Concentrator (5k MWCO PRES) and cleaved with Factor Xa (1% w/w ratio of
final protein weight) (New England BioLabs, Inc.). Cleavage was performed at 4 degrees Celsius
for 8 hours in CB. The protein was then loaded onto a Superdex75 column (20mM Tris-HcL, pH
7.5, 200mM NaCl, 1mM EDTA).
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MS/HPLC – Aar-MBP
Prior to size exclusion on the SuperdexG75 column, protein samples were passed over a
G-25 column using Low salt buffer (10mM NaCl, 10 mM NH4C2H3O2). Samples were separated
using the 1290 Infinity HPLC system (Agilent Technologies) using a 5-90% acetonitrile in
water gradient with 0.1% formic acid and a Biobasic 18 HPLC column. (Thermofisher). The
column compartment was equilibrated to 50 degrees Celsius and absorbances were taken at
280nm. Mass spectrometry spectra were obtained 8530 Accurate-Mass Q-TOF LC/MS (Agilent
Technologies).
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Results
SDS-PAGE gel electrophoresis
One hypothesis at the inception
of the project proposed that Aar was a
transcription factor, suggesting that it is
likely short-lived within the cell.
Additionally, whole cell assays did not
contain any evidence of a protein Aar’s
size. Aar was covalently linked to fusion
partners to enhance stability and
expression. Various purification strategies
including centrifugation and affinity

Figure 2. SDS-PAGE gel of Ubiquitin-Aar after
purification on nickel (Ni2+) and sulfopropyl
resin. Pure Ubiquitin-Aar can be visualized
around the 17 kDa standard in the final lane.

chromatography were used to purify Ubiquitin-Aar. The Ni2+ column flow through (Figure 2,
lane 2) and Ni2+ wash (Figure 2, lane 3) contained many different protein bands. Additional
purification steps including a sulfopropyl column and centrifugation resulted in a single faint
band around the expected molecular weight (17.9 kDa) (Figure 2, lane 7). Pure, full-length
Ubiquitin-Aar was subjected to further experimentation to determine the secondary structure.
Circular Dichroism
Circular dichroism (CD) was employed to analyze the secondary structure of UbiquitinAar. Differential absorbance of left and right polarized UV light by chiral centers was used to
identify fundamental protein secondary structures (Figure 3). The solid line (Figure 3) is
representative of α-helical structure, while the long dashed line (Figure 3) delineates a
predominately β-sheet structure and the short dashed line (Figure 3) is representative of irregular
14

structure. The differential absorption
results in a spectrum that is representative
of the conserved peptide backbone
geometries associated with protein
secondary structures. The collected
Ubiquitin spectrum was compared to
published data spectrum (Larios, Li,
Schulten, Kihara, & Gruebele, 2004).
Figure 3. Far UV circular dichroism (CD)
associated
with
different
secondary
structures. Solid line: α-helix, long dashed
line: type I β-turn; cross dashed line: poly
(Pro) II helix; short dashed line: irregular
structure. α-helical spectra are characterized
by negative bands at 222nm and 208nm,
while β-sheet spectra show a negative band at
218nm. Adapted figure (Kelly, Jess, & Price,
2005).

Although the signal to noise ratio was
high in the current data, the Larios et al.
profile is comparable to the collected
Ubiquitin spectrum (3-10µM and 5µM,
respectively) (Larios et al., 2004). CD
experiments were then conducted on
Ubiquitin-Aar to determine structural

1
-1

characteristics.

-3
-5

The introduction of Aar bound to

CD (mdeg)

Ubiquitin

-7
-9

Aar (pH 7.5)

-11

Aar (pH 7.0)

Ubiquitin (Figure 4, red & Figure 4, blue)
changed the absorbance spectra markedly

-13

from monomeric Ubiquitin (Figure 4,

-15
200

210

220

230

240

250

Wavelength (nm)

green), resulting in two characteristic peaks

Figure 4. CD spectra for Ubiquitin and
Ubiquitin-Aar complexes (pH 7.0 and pH 7.5,
respectively). Differential absorbance readings
were taken within the 200 to 250 nm range. Tests
were done in triplicate and averaged.
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at 208 and 222 nm (Figure 4, red & Figure
4, blue). Qualitatively, the peaks suggest

the presence of a predominately alpha-helical structure as opposed to the random coil spectrum
for Ubiquitin (Figure 4, green). Unpublished data by the Berndsen laboratory suggests Ubiquitin
is denatured when sonicated above 30% intensity, suggesting the spectra for Ubiquitin-Aar (pH
7.0) (Figure 4, red) and Ubiquitin-Aar (pH 7.5) (Figure 4, blue) are not substantially altered by
the presence of ubiquitin. There are potential intramolecular chemical interactions between
Ubiquitin and Aar, likely slightly altering the spectra. Due to potential artifacts in the data and
unsuccessful cleavage, Aar covalently linked to maltose binding protein (MBP) was used for all
subsequent purification experiments.
Purification – MBP-Aar
Experiments to cleave Aar from its fusion partner Ubiquitin were unsuccessful. Due to
the availability, stability and purification ease, MBP was used as a fusion partner for further
testing. Various experiments including size exclusion chromatography and HPLC/MS were
conducted to purify the construct. The protein samples were subjected to HPLC/MS peptide
mapping after chromatography purification to confirm cleavage. The mass spectra for peptide
identification were calculated manually to ensure accuracy. After deconvolusion of multiplycharged ion series, the uncleaved MBP-Aar sample had single peak (Figure 5A). The
experimental molecular mass, 52.1 kDa (m/z 1.022) (Figure 5A), was compared to its theoretical
molecular mass, 51.0 kDa, confirming the presence of uncleaved MBP-Aar. Cleaved MBP-Aar
was also subjected to HPLC/MS analysis. Two variants of Aar, Aar-monomer and Aar-dimer,
eluted in two distinct HPLC peaks (Figure 5B). The experimental molecular mass of Aarmonomer, 8.4 kDa (m/z ratio 1.091)(Figure 5A), was compared to its theoretical molecular mass,
8.5 kDa. Another peak was present in the spectrum (Figure 5B). Deconvolution revealed a
species with a molecular weight of 16.8 kDa (Figure 5B), suggesting the formation of an Aar
16

dimer. Smaller peaks also exist in the spectrum around 30 seconds (Figure 5A, Figure 5B),
however these peaks are the result of an overloaded column and had no effect on data acquisition
and analysis. Once cleavage was confirmed, other chromatographatic techniques were utilized to
separate monomeric Aar from dimeric Aar and MBP.
A)

52.086 kDa

B)
16.8039 kDa

8.4041 kDa

Figure 5. Chromatic separation when a 5-90 & acetonitrile gradient in water was used with
0.1% formic acid as the organic mobile phase. Analytes: (A) MBP-Aar (B) Aar (dimer),
Aar (monomer).

Size chromatography was utilized to separate high molecular weight species from low
molecular weight species. Fractions from the sizing column were selected based on OD280
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absorbances (Figure 6A). Selected samples were run on an SDS-PAGE gel to determine purity.
Lanes 36, 44 and 46 (Figure 6B) contained MBP and other contaminates, while lanes 49 and 56
(Figure 6B) contained pure MBP. Lane 62 (Figure 6B) contains a single faint band around
7.4kDa, the predicted molecular weight of monomeric Aar, suggesting that pure, monomeric Aar
was obtained.
A)

B)
1.8
1.6
1.4
1.2
OD280

1
0.8
0.6
0.4
0.2
0
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
Fraction

Figure 6. A) Size exclusion absorbance profiles for cleaved Aar-MBP. B) SDS-PAGE
gel electrophoresis corresponding to the fractional data. Fraction 62 contains pure,
dilute Aar-monomer.
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Discussion
Here, we present viable strategies for the purification of Aar from fusion partners,
Ubiquitin and MBP. Using chromatographic methods (e.g affinity chromatography and size
exclusion chromatography), Aar and its fusion proteins were purified from other cellular
proteins. We expect that this purification strategy can be used to purify isotopically labeled Aar
to study three-dimensional structural characteristics.
Aar was covalently linked to Ubiquitin due to the hypothesized ephemeral nature of Aar
at physiological conditions. Purification experiments were successful (Figure 2, lane 7), but
cleavage was not attainable. Unsuccessful cleavage was unexpected because the Ubiqutin-Aar
construct contained a linear epitope recognized by the TEV protease. Unsuccessful cleavage is
likely the result of either serine protease inhibitors (PMSF) present in the sample, an occluded
active site due to conformational restrictions, or denaturation due to sonication. We cannot
comment on the validity of Ubiqutuin-Aar cleavage with TEV because the experiments were not
conducted with pure protein. Since MBP-Aar cleaved, a valid cleavage strategy for UbiquitinAar was not pursued.
Purification and cleavage experiments were conducted on MBP-Aar. To confirm
cleavage of MBP-Aar, HPLC/MS (Q-TOF) was conducted. There is evidence of full length
MBP-Aar (Figure 5, A), dimerized Aar and monomeric Aar (Figure 5, B). The experimental
molecular weight, 8.4kDa, did not coincide with the predicted molecular weight. The disparity in
molecular weight is likely due to discrepancies between the sequence used for prediction,
Ubiquitin-Aar, and the sequencing information generated by the Nataro laboratory. However, the
calculated difference, 0.1 kDa, between the theoretical molecular weight and the experimental
molecular weight is likely the result of an additional amino acid in the Ubiquitin-Aar sequence.
19

Several other artifacts are present in the HPLC/MS spectra.
Both HPLC/MS spectra (Figure 5, A and B) contain other insignificant peaks. The Aar
HPLC/MS spectrum contains additional peaks around six minutes (Figure 5, A and B). Thorough
analysis was not conducted on these species, but m/z ratios suggested the presence of fragmented
protein. Furthermore, the spectra do not have any species around 42.5 kDa, the theoretical
molecular weight of MBP. These peaks were expected because separation did not occur until
after HPLC/MS was conducted. The absence of MBP in the spectrum is likely the result of
precipitation during the cleavage process. Although MBP was absent from the spectra, the
precursors and final product were present, proving that successful cleavage occurred. Once
cleavage was confirmed, measures were taken to separate Aar from dimeric Aar and MBP.
We have established a viable purification strategy for Aar using MBP as a fusion partner.
Isotopically-labeled Aar is being purified for future studies, likely leading to high resolution
structure through multi-dimensional NMR. There is evidence that Aar binds to AggR. However,
there is no structural data to validate the binding mechanism. Future experiments will investigate
physical interactions between Aar residues and AggR residues. Controlling this pathway through
synthetic or natural methods could lead to novel pharmaceuticals, protecting kids from
pathogenic species such as EAEC.
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Supplemental Methods
X-ray Crystallography
Preceding cleavage, MBP-Aar crystal screens were set using Index 1, Index 2, PEGRx1,
PEGRx2, Natrix1, Natrix 2, and PEG/Ion solution screens (Hampton Research). Screens were set
using the hanging drop vapor diffusion method at 26 degrees Celsius. Two µLs of protein
solution (10mg/mL) were mixed with 2 µLs of well solution.
Supplemental Results
X-ray Crystallography
Crystal trays were set using full length MBP-Aar. Condition 64 (0.005M Cobalt(II),
0.005M Nickle(II), 0.005 cadmium chloride hydrate, 0.005M magnesium chloride hydrate, 0.1M
HEPES, pH 7.5, 12% w/v PEG 3350) (Index 2) contained granular precipitate. Multiple wells
were set, but only granular crystals have formed. Future experiments should optimize the
condition for three-dimensional (3D) crystals.
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